4/17
10:27 am
crbp
Mizuho Sees Strong Risk-Reward in Corbus Pharmaceuticals Holdings, Inc. (CRBP) Near Cash Value [Yahoo! Finance]
Low
Report
Mizuho Sees Strong Risk-Reward in Corbus Pharmaceuticals Holdings, Inc. (CRBP) Near Cash Value [Yahoo! Finance]
4/14
08:09 am
crbp
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity [Yahoo! Finance]
Low
Report
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity [Yahoo! Finance]
4/14
08:00 am
crbp
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
Low
Report
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
4/7
08:00 am
crbp
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
Low
Report
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
3/18
08:00 am
crbp
Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit
Medium
Report
Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit
3/11
10:35 pm
crbp
How Much Upside is Left in Corbus Pharmaceuticals (CRBP)? Wall Street Analysts Think 318.33% [Yahoo! Finance]
Medium
Report
How Much Upside is Left in Corbus Pharmaceuticals (CRBP)? Wall Street Analysts Think 318.33% [Yahoo! Finance]
3/10
11:02 am
crbp
Corbus Pharmaceuticals (CRBP) had its price target raised by Oppenheimer Holdings, Inc. from $53.00 to $57.00. They now have an "outperform" rating on the stock.
Medium
Report
Corbus Pharmaceuticals (CRBP) had its price target raised by Oppenheimer Holdings, Inc. from $53.00 to $57.00. They now have an "outperform" rating on the stock.
3/9
07:38 am
crbp
Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update [Yahoo! Finance]
High
Report
Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update [Yahoo! Finance]
3/9
07:30 am
crbp
Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
High
Report
Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
2/26
03:27 am
crbp
Corbus Pharmaceuticals Touts “Catalyst-Rich” 2026 With CRB-701 and CRB-913 Data Readouts Ahead [Yahoo! Finance]
Medium
Report
Corbus Pharmaceuticals Touts “Catalyst-Rich” 2026 With CRB-701 and CRB-913 Data Readouts Ahead [Yahoo! Finance]
2/19
07:26 am
crbp
Corbus Pharmaceuticals (NASDAQ:CRBP) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
Medium
Report
Corbus Pharmaceuticals (NASDAQ:CRBP) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
2/12
08:29 am
crbp
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference [Yahoo! Finance]
Medium
Report
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference [Yahoo! Finance]
2/12
08:00 am
crbp
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
Medium
Report
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
2/6
06:06 pm
crbp
Corbus Pharmaceuticals: Maintaining 'Hold' As Summer 2026 Obesity Data Catalyst Looms [Seeking Alpha]
Low
Report
Corbus Pharmaceuticals: Maintaining 'Hold' As Summer 2026 Obesity Data Catalyst Looms [Seeking Alpha]